Skip to main content

Research Collaboration

This page is currently available in Chinese

Below is a summary in English of what this research program covers. For the full detail — including hospital partnerships and clinical studies — see the Chinese version.

View 117 research directions

Evidence Architecture

Three layers of evidence, outside in

Real medical credibility follows a progression: "people close to you are already using it → this ingredient has research behind it → safety data is available to check."

01

Endorsed by top-tier hospitals

The clinical evidence closest to you: doctors at 100+ top-tier hospitals use it as a supportive nutrition program in child health, pediatric rehabilitation, psychiatry, neurology, and nutrition departments.

02

Core ingredients in published research

PQQ, PS, and ferulic acid aren't new ingredients — all have peer-reviewed research published in journals like CNS Neuroscience and Translational Psychiatry.

03

Raw-material-level safety data available

Every ingredient has an SDS safety data sheet, with no serious adverse-reaction reports over years of use.

Hospital Network

Partner hospitals and departments (selection)

Departments at the hospitals below already use Chienomoto as a supportive nutrition program, or have conducted clinical observation studies. Contact us for the complete list.

Guangzhou Women and Children's Medical Center

Pediatric Rehabilitation · ADHD / developmental delay

Wenzhou Kangning Hospital

Psychiatry · subthreshold depression research

Hunan Children's Hospital

Rehabilitation · pediatric attention issues

Guangdong Second Provincial People's Hospital

Nutrition · general applications

Affiliated Brain Hospital of Guangzhou Medical University

Child & adolescent · Nutrition

Guangdong Women and Children Hospital

Pediatric Rehabilitation · ADHD / developmental delay

※ On "hospital endorsement": Partner hospitals use Chienomoto as a supportive nutrition program alongside a doctor's treatment plan. This does not represent an official institutional endorsement or prescription recommendation — the specific plan is always determined by the treating physician based on the individual's situation.

Hospital-led Studies

Top-tier hospital research (selection)

The studies below were all led by partner hospitals, with results published as conference posters or in peer-reviewed journals. We've extracted and plainly translated only the parts most relevant to families.

A · ADHD / Attention

From clinical to basic science and back to clinical: developing ADHD healthcare products using a zebrafish model

2024 poster · April · joint medical school research

A combined study using a zebrafish model and clinical observation, exploring the potential mechanism of the core ingredient combination in regulating attention in ADHD. What this means for families: a preliminary, mechanism-level explanation for why this formula works in ADHD contexts.

Zebrafish model ADHD research poster
B · Subthreshold depression

Supportive nutritional intervention research with Chienomoto in a subthreshold depression population

Affiliated Brain Hospital of Guangzhou Medical University · Child & Adolescent Psychology

A supportive nutritional intervention study for people with subthreshold depression who don't yet require medication. What this means for families: this is the "gray zone" parents of teens worry about most — the study attempts to answer what kind of supportive role Chienomoto can play here.

Subthreshold depression supportive nutrition research
C · Developmental delay

Multi-center clinical research project on the use of Chienomoto in children with global developmental delay officially launched

Hunan Children's Hospital · Rehabilitation

This project focuses on children with global developmental delay, aiming to further verify Chienomoto's application value and safety in this population through multi-center, prospective observation, and to build a more systematic body of clinical evidence. We will continue to follow the research and responsibly report interim results. What this means for families: insight into where supportive use of Chienomoto may help children with developmental delay.

D · Pediatric rehabilitation

Clinical observation of Chienomoto as a supportive ADHD intervention at Guangzhou Women and Children's Medical Center's Rehabilitation Department

Guangzhou Women and Children's Medical Center · Rehabilitation

Real-world data accumulated through long-term clinical collaboration, focused on actual family-reported feedback from combining methylphenidate-class medication with Chienomoto's supportive nutrition. What this means for families: the real-world data source closest to your own situation.

Compound by Compound

Four core ingredients, explained one by one

Don't trust a "secret formula." Every legitimate functional food should lay its ingredients out in the open.

Ferulic acid source: rice bran
FA Ferulic Acid Source: rice bran

Antioxidant · neuroinflammation regulation · mood pathways

Ferulic acid: a natural polyphenol "neural repair specialist"

Ferulic acid is a natural polyphenolic compound widely found in grains and plants, with strong antioxidant and anti-neuroinflammatory effects. A 2023 review in CNS Neuroscience & Therapeutics discussed it as a potential adjunctive candidate for depression, with mechanisms involving monoamine neurotransmitters, neuroplasticity, and neuroinflammation.

Key literature: "Ferulic Acid as a Therapeutic Agent in Depression" (DOI: 10.1111/cns.14265); "Effects of Ferulic Acid and Angelica Archangelica Extract on Behavioral and Psychological Symptoms in Frontotemporal Dementia and Dementia with Lewy Bodies" (Geriatr Gerontol Int. 2011)

PQQ source: natto and fermented foods
PQQ Pyrroloquinoline quinone Source: natto, fermented foods

Mitochondrial biogenesis · neural energy metabolism

PQQ: refreshing the neuron's "power plant"

PQQ is a vitamin-like cofactor whose key role is promoting mitochondrial biogenesis. When the brain is under chronic stress, inflammation, or aging, declining mitochondrial function is one of the shared mechanisms behind cognitive and mood issues. PQQ has been used as a dietary supplement in Japan and the US for years.

Key literature: "Effects of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study" (J. Am. Coll. Nutr., DOI: 10.1080/07315724.2021.1962770)

Angelica root extract source: dried root
Angelica Archangelica Angelica Archangelica Root Extract Source: dried angelica root

Microcirculation support · traditional medicine synergy

Angelica Archangelica: microcirculation support

Angelica Archangelica root is a classic ingredient in traditional Chinese medicine used to nourish and invigorate blood. Modern research focuses on its polysaccharides, ferulic acid, and imperatorin-type active compounds and their effects on microcirculation, inflammation, and oxidative stress. In Chienomoto's formula, it works in synergy with ferulic acid, PQQ, and PS, especially in applications for older adults dealing with mood and cognitive decline.

Key literature: "Effects of Ferulic Acid and Angelica Archangelica Extract on Mild Cognitive Impairment" (J. Alzheimer's Dis. Reports 4 (2020) 393–398, DOI: 10.3233/ADR-200211)

PS source: soy lecithin
PS Phosphatidylserine Source: soy lecithin

Neuronal membrane core · attention · memory

Phosphatidylserine: an essential "building block" of neuronal membranes

Phosphatidylserine is a core component of neuronal cell membranes, involved in neurotransmitter release and maintaining receptor function. The body's ability to synthesize it declines with age after adulthood. The FDA's 2003 qualified health claim linking PS to improved cognitive function is a landmark recognition of PS in cognitive nutrition.

Key literature: "Phosphatidylserine in the Treatment of Pediatric Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis" (JACM Vol.27, No.4, 2021, pp.312–322, DOI: 10.1089/acm.2020.0432)

Safety Profile

Safety data: every ingredient, checkable

SDS (Safety Data Sheet) sources exist for every raw material, and we're happy to lay them out. Here's a simplified version.

Ingredient Acute toxicity Long-term safety Known contraindications SDS source
PQQVery lowYears of food-grade use in Japan / USNone reportedMitsubishi Gas Chemical SDS
PS (Phosphatidylserine)Very lowFDA qualified health claim grantedCaution for those with soy allergyManufacturer SDS · public
Ferulic acidVery lowNaturally present in foodPregnant women should consult a doctorManufacturer SDS · 2020.06
Angelica root extractFood-medicine homologyMillennia of use in ChinaCaution during menstruation / bleeding tendencyPharmacopoeia & manufacturer data

Suitable for

Children 1+, teens, adults, and older adults.

Use with caution / not suitable

Those with severe soy allergy, pregnant or breastfeeding women, those with bleeding tendencies, or those on anticoagulants — please consult a doctor or our team first.

Not for use by

Children under 1 year old, or anyone with a confirmed allergy to any formula ingredient.

Clinical Application

Comorbidity intervention pathway: how it's used clinically

Families often ask "can Chienomoto be combined with the medication we're already taking?" — here's a common pairing pattern seen in clinical collaboration.

Typical pathway: children with ADHD · methylphenidate-class medication + Chienomoto supportive nutrition

  1. 1

    Specialist evaluation & diagnosis

    ADHD diagnosis and medication plan completed by child psychiatry / developmental-behavioral pediatrics

  2. 2

    Primary medication starts

    Core treatment medication used per doctor's prescription

  3. 3

    Side effects assessed

    Tracking appetite, sleep, mood, and growth indicators

  4. 4

    Chienomoto added

    Introduced on a doctor's or advisor's recommendation, for side-effect management and nutritional support

  5. 5

    Long-term tracking & adjustment

    Reassessed every 3 months, with the doctor deciding whether to adjust the primary medication

※ Important boundary: The pathway above reflects a common pattern observed in clinical collaboration — it is not a "standard protocol." Every child and every older adult is different. Whether, when, and how to add Chienomoto should follow the guidance of the treating physician and our team.

Have a specific question?
Our team can help based on your family's situation

Tell us what medication your child or parent is currently on, their condition, and what the doctor has said — we'll offer specific, actionable suggestions based on our clinical collaboration experience.